Stay updated with breaking news from Access Bio Convertible Notes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today...
/PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), the leading horizontal platform for cell programming, today announced its results for...
$168 million of Total revenue in Q1 2022, representing an increase of 282% over Q1 202111 new Cell Programs added in Q1 2022, representing 175% gr...